United States · FDA National Drug Code directory
Tembexa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64678-010_bf0186cb-f9bf-49ea-904b-6f8dd72a2590
- Product NDC
- 64678-010
- Form
- TABLET, FILM COATED
- Composition / generic term
- Brincidofovir
- Labeler
- Emergent BioDefense Operations Lansing LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20220420
- Source listing expiry
- 20271231
Source-listed ingredients
- BRINCIDOFOVIR — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 TABLET, FILM COATED in 1 BLISTER PACK (64678-010-01) · 64678-010-01
- 4 TABLET, FILM COATED in 1 BLISTER PACK (64678-010-02) · 64678-010-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →